Suppr超能文献

长链非编码RNA CCAT2对癌症代谢的等位基因特异性重编程

Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2.

作者信息

Redis Roxana S, Vela Luz E, Lu Weiqin, Ferreira de Oliveira Juliana, Ivan Cristina, Rodriguez-Aguayo Cristian, Adamoski Douglas, Pasculli Barbara, Taguchi Ayumu, Chen Yunyun, Fernandez Agustin F, Valledor Luis, Van Roosbroeck Katrien, Chang Samuel, Shah Maitri, Kinnebrew Garrett, Han Leng, Atlasi Yaser, Cheung Lawrence H, Huang Gilbert Y, Monroig Paloma, Ramirez Marc S, Catela Ivkovic Tina, Van Long, Ling Hui, Gafà Roberta, Kapitanovic Sanja, Lanza Giovanni, Bankson James A, Huang Peng, Lai Stephen Y, Bast Robert C, Rosenblum Michael G, Radovich Milan, Ivan Mircea, Bartholomeusz Geoffrey, Liang Han, Fraga Mario F, Widger William R, Hanash Samir, Berindan-Neagoe Ioana, Lopez-Berestein Gabriel, Ambrosio Andre L B, Gomes Dias Sandra M, Calin George A

机构信息

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Department of Biology & Biochemistry, University of Houston, Houston, TX 77204, USA.

出版信息

Mol Cell. 2016 Feb 18;61(4):520-534. doi: 10.1016/j.molcel.2016.01.015. Epub 2016 Feb 4.

Abstract

Altered energy metabolism is a cancer hallmark as malignant cells tailor their metabolic pathways to meet their energy requirements. Glucose and glutamine are the major nutrients that fuel cellular metabolism, and the pathways utilizing these nutrients are often altered in cancer. Here, we show that the long ncRNA CCAT2, located at the 8q24 amplicon on cancer risk-associated rs6983267 SNP, regulates cancer metabolism in vitro and in vivo in an allele-specific manner by binding the Cleavage Factor I (CFIm) complex with distinct affinities for the two subunits (CFIm25 and CFIm68). The CCAT2 interaction with the CFIm complex fine-tunes the alternative splicing of Glutaminase (GLS) by selecting the poly(A) site in intron 14 of the precursor mRNA. These findings uncover a complex, allele-specific regulatory mechanism of cancer metabolism orchestrated by the two alleles of a long ncRNA.

摘要

能量代谢改变是一种癌症特征,因为恶性细胞会调整其代谢途径以满足能量需求。葡萄糖和谷氨酰胺是为细胞代谢提供能量的主要营养物质,而利用这些营养物质的途径在癌症中常常发生改变。在此,我们表明,位于癌症风险相关单核苷酸多态性rs6983267所在的8q24扩增子上的长链非编码RNA CCAT2,通过以不同亲和力结合切割因子I(CFIm)复合体的两个亚基(CFIm25和CFIm68),在体外和体内以等位基因特异性方式调节癌症代谢。CCAT2与CFIm复合体的相互作用通过选择前体mRNA内含子14中的聚腺苷酸化位点,微调谷氨酰胺酶(GLS)的可变剪接。这些发现揭示了一种由长链非编码RNA的两个等位基因精心编排的癌症代谢复杂的、等位基因特异性调控机制。

相似文献

1
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2.
Mol Cell. 2016 Feb 18;61(4):520-534. doi: 10.1016/j.molcel.2016.01.015. Epub 2016 Feb 4.
2
Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation.
Mol Cell. 2018 Jan 4;69(1):62-74.e4. doi: 10.1016/j.molcel.2017.11.031. Epub 2017 Dec 21.
3
Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation.
Genes Cells. 2010 Sep 1;15(9):1003-13. doi: 10.1111/j.1365-2443.2010.01436.x. Epub 2010 Jul 29.
5
Pre-messenger RNA cleavage factor I (CFIm): potential role in alternative polyadenylation during spermatogenesis.
Biol Reprod. 2008 Mar;78(3):472-82. doi: 10.1095/biolreprod.107.064774. Epub 2007 Nov 21.
6
SAM homeostasis is regulated by CFI-mediated splicing of MAT2A.
Elife. 2021 May 5;10:e64930. doi: 10.7554/eLife.64930.
8
CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function.
RNA. 2016 Jun;22(6):830-8. doi: 10.1261/rna.055939.116. Epub 2016 Apr 19.
9
Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
Nucleic Acids Res. 2006;34(21):6264-71. doi: 10.1093/nar/gkl794. Epub 2006 Nov 10.
10
Knockdown of pre-mRNA cleavage factor Im 25 kDa promotes neurite outgrowth.
Biochem Biophys Res Commun. 2012 Sep 7;425(4):848-53. doi: 10.1016/j.bbrc.2012.07.164. Epub 2012 Aug 7.

引用本文的文献

3
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases.
MedComm (2020). 2025 Jun 25;6(7):e70120. doi: 10.1002/mco2.70120. eCollection 2025 Jul.
5
Characterization and molecular targeting of CFIm25 (NUDT21/CPSF5) mRNA using miRNAs.
FASEB J. 2025 Jan 31;39(2):e70324. doi: 10.1096/fj.202402184R.
6
HuR controls glutaminase RNA metabolism.
Nat Commun. 2024 Jul 4;15(1):5620. doi: 10.1038/s41467-024-49874-x.
7
DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma.
PLoS Genet. 2024 Mar 21;20(3):e1011216. doi: 10.1371/journal.pgen.1011216. eCollection 2024 Mar.
9
HIV-1-induced translocation of CPSF6 to biomolecular condensates.
Trends Microbiol. 2024 Aug;32(8):781-790. doi: 10.1016/j.tim.2024.01.001. Epub 2024 Jan 23.
10
Tectorigenin Inhibits Glycolysis-induced Cell Growth and Proliferation by Modulating LncRNA CCAT2/miR-145 Pathway in Colorectal Cancer.
Curr Cancer Drug Targets. 2024;24(10):1071-1079. doi: 10.2174/0115680096274757231219072003.

本文引用的文献

1
MYC, Metabolism, and Cancer.
Cancer Discov. 2015 Oct;5(10):1024-39. doi: 10.1158/2159-8290.CD-15-0507. Epub 2015 Sep 17.
2
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
Blood. 2015 Sep 10;126(11):1346-56. doi: 10.1182/blood-2015-01-621870. Epub 2015 Jul 17.
3
Metabolic pathways promoting cancer cell survival and growth.
Nat Cell Biol. 2015 Apr;17(4):351-9. doi: 10.1038/ncb3124. Epub 2015 Mar 16.
4
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis.
Cancer Cell. 2015 Feb 9;27(2):271-85. doi: 10.1016/j.ccell.2014.11.024. Epub 2015 Jan 29.
7
CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
Nature. 2014 Jun 19;510(7505):412-6. doi: 10.1038/nature13261. Epub 2014 May 11.
8
Expression of glutaminase is upregulated in colorectal cancer and of clinical significance.
Int J Clin Exp Pathol. 2014 Feb 15;7(3):1093-100. eCollection 2014.
9
Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect.
Mol Cell. 2014 Jan 9;53(1):88-100. doi: 10.1016/j.molcel.2013.11.004. Epub 2013 Dec 5.
10
MicroRNAs and other non-coding RNAs as targets for anticancer drug development.
Nat Rev Drug Discov. 2013 Nov;12(11):847-65. doi: 10.1038/nrd4140.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验